We recently compiled a list of the Louis Navellier’s Top 15 Long-Term Stock Picks. In this article, we are going to take a ...

We recently published a list of 15 Best NASDAQ Dividend Stocks To Buy. In this article, we are going to take a look at where ...

Amgen Inc (AMGN) stock saw a modest uptick, ending the day at $268.94 which represents a slight increase of $1.84 or 0.69% from the prior close of $267.1. The stock opened at $269.33 and touched a low ...

Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

AMGN is a #3 (Hold) on the Zacks Rank, with a VGM Score of B. Momentum investors should take note of this Medical stock. AMGN has a Momentum Style Score of B, and shares are up 1.4% over the past ...

Amgen Inc (AMGN) stock saw a decline, ending the day at $262.23 which represents a decrease of $-1.98 or -0.75% from the prior close of $264.21. The stock opened at $260.79 and touched a low of ...

The latest trading session saw Amgen (AMGN) ending at $267.10, denoting a -1.14% adjustment from its last day's close. The stock fell short of the S&P 500, which registered a gain of 0.12% for the ...

Piper Sandler analyst David Amsellem reiterated a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $310.00. The ...

Jefferies analyst Michael Yee maintained a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $350.00. The company’s ...

I will explain in detail why I am a "hold" on the stock. AMGN is a biotechnology company specializing in the development and discovery of innovative therapies. AMGN produces medicines in these ...

Amgen (AMGN) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.